Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  ObesityType 2 DiabetesIssue 602

Birth Weight Inversely Impacts Diabetes Risk

More weight gain than expected from 48 months to adulthood is tied to impaired fasting glucose, diabetes....


Birth weight is inversely associated with adult fasting-glucose levels and with the risk of impaired fasting glucose (IFG) or type 2 diabetes mellitus (DM), according to a study.

Shane A. Norris, Ph.D., from the University of the Witwatersrand in Johannesburg, South Africa, and colleagues examined the associations of birth weight and weight gain in infancy and early childhood with DM risk in 6,511 young adults from low- and middle-income countries. Weight was measured at birth, at 24 and 48 months, and in adulthood, and the deviation from expected weight gain between these ages (conditional weight gain [CWG]) was calculated.

The investigators found an inverse association for birth weight with adult fasting-glucose and the risk of IFG/DM (odds ratio [OR], 0.91 per standard deviation [SD]). Weight at 24 and 48 months and CWG at 0 to 24 and 24 to 48 months were not related to fasting-glucose or IFG/DM. CWG at 48 months to adult correlated positively with IFG/DM (OR, 1.32 per SD). Birth weight, weight at 24 to 48 months, and CWG at 0 to 24 months had inverse associations with fasting-glucose and IFG/DM, after adjusting for adult waist circumference. Birth weight had no relation with insulin resistance homeostasis model assessment (IR-HOMA), but higher CWG at 0 to 24, 24 to 48, and 48 months to adult predicted significantly higher IR-HOMA. Birth weight had an inverse association with IR-HOMA after adjusting for adult waist circumference.

"Lower birth weight and accelerated weight gain after 48 months are risk factors for adult glucose intolerance," the authors write.

Published online before print November 18, 2011, doi: 10.2337/dc11-0456 Diabetes Care November 18, 2011



Bookmark and Share | Print | Category | Home

This article originally posted 02 December, 2011 and appeared in  ObesityType 2 DiabetesIssue 602

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?